Spinal cord dose in limited stage small cell lung cancer: a preliminary quality assurance review committee (QARC) report on CALGB 39808, using target thoracic radiotherapy (TRT) doses of 60 – 70 Gy
M. Giulia Cicchetti(Providence College), Thomas J. FitzGerald(University of Massachusetts Chan Medical School), M. Green(University of Charleston), S. Bushe(Providence College), Ingrid Koehler(Providence College), Alan P. Lyss(Missouri Baptist Medical Center), Kathleen Briggs(Providence College), Jeffrey A. Bogart(SUNY Upstate Medical University), Karina Bertsch(Rhode Island Hospital), Fran Laurie(University of Massachusetts Chan Medical School), A. Turrisi(University of Charleston), James E. Herndon(Duke University)
International Journal of Radiation Oncology*Biology*Physics
November 1, 2001
Cited by 1
Related Papers
Critical Impact of Radiotherapy Protocol Compliance and Quality in the Treatment of Advanced Head and Neck Cancer: Results From TROG 02.02
|Journal of Clinical Oncology|2010|806
Factors Predictive of Survival Among 337 Patients With Mesothelioma Treated Between 1984 and 1994 by the Cancer and Leukemia Group B
|CHEST Journal|1998|508
Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial
|Journal of Clinical Oncology|2014|394
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2021|255
Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG 1 1For a complete list of the members of the Children’s Oncology Group Soft Tissue Sarcoma Committee (formerly Intergroup Rhabdomyosarcoma Group) representing the Children’s Oncology Group and the Quality Assurance Review Center, see the Appendix.
|International Journal of Radiation Oncology*Biology*Physics|2001|213